FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...

New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.

Does your family make you sick at the holidays? We’re not just talking about catching a bug. It’s the emotional toll, which ...

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Dec. 9, 2024 -- The updated COVID vaccines for 2024-2025 are officially here, designed to target the latest variants and offer robust protection — but getting Americans to roll up their sleeves ...